Stocklytics Platform

Cash Flow

publish
Cash flow is the lifeblood of any company, and at Stocklytics, we bring you a powerful tool to evaluate stocks based on their cash-generating abilities. The Cash Flow Screener ranks stocks in descending order of Operating Cash Flow, giving you instant access to companies with robust cash flow management.
name
arrow_downwardOPERATING CF PRICE $ CHANGE % CHANGE INVESTING CF FINANCING CF FREE CASH FLOW
Asset logo for symbol DMTK
DMTKDermTech
-$77.04M$55.65$0.000.00%_$6.07M-$77.88MAI Analysis
Asset logo for symbol OMIC
OMICSingular Genomics Systems
-$77.45M$16.42$0.20arrow_drop_up1.23%_$696.00K-$74.61MAI Analysis
Asset logo for symbol CCCC
CCCCC4 Therapeutics
-$77.80M$6.35-$0.22arrow_drop_down3.34%_$45.48M-$108.54MAI Analysis
Asset logo for symbol OUST
OUSTOuster
-$78.77M$6.06-$0.11arrow_drop_down1.78%_$15.65M-$140.89MAI Analysis
Asset logo for symbol TERN
TERNTerns Pharmaceuticals
-$78.99M$10.02-$0.02arrow_drop_down0.19%_$42.29M-$67.78MAI Analysis
Asset logo for symbol KZR
KZRKezar Life Sciences
-$79.07M$0.57-$0.01arrow_drop_down1.72%_$638.00K-$83.45MAI Analysis
FAMI
FAMIFarmmi
-$79.35M$0.24$0.000.00%_$11.01M-$75.75MAI Analysis
Asset logo for symbol HUT
HUTHut 8 Mining
-$79.39M$11.17-$0.26arrow_drop_down2.27%_-$33.45M-$27.29MAI Analysis
Asset logo for symbol RPTX
RPTXRepare Therapeutics
-$79.60M$3.52$0.02arrow_drop_up0.57%_$842.00K-$129.09MAI Analysis
Asset logo for symbol IFS
IFSIntercorp Financial Services
-$79.83M$24.51-$0.41arrow_drop_down1.64%_-$3.01B$2.44BAI Analysis
Asset logo for symbol CARA
CARACara Therapeutics
-$79.90M$0.30-$0.00arrow_drop_down2.26%_$38.15M-$94.45MAI Analysis
Asset logo for symbol STOK
STOKStoke Therapeutics
-$79.95M$13.75-$1.39arrow_drop_down9.18%_$53.00M-$82.68MAI Analysis
Asset logo for symbol ATXS
ATXSAstria Therapeutics
-$80.38M$12.65$0.30arrow_drop_up2.42%_$88.39M-$68.47MAI Analysis
Asset logo for symbol IOBT
IOBTIO Biotech
-$80.69M$1.13-$0.06arrow_drop_down5.04%_$71.86M-$72.06MAI Analysis
Asset logo for symbol HUMAW
HUMAWHumacyte
-$80.69M$1.65-$0.11arrow_drop_down6.25%_$4.50M-$75.58MAI Analysis
Asset logo for symbol HUMA
HUMAHumacyte
-$80.69M$5.20-$0.25arrow_drop_down4.58%_$4.50M-$75.58MAI Analysis
Asset logo for symbol LNZA
LNZALanzaTech Global
-$81.12M$1.47-$0.04arrow_drop_down2.64%_$148.18M-$105.84MAI Analysis
Asset logo for symbol ASLE
ASLEAerSale Corporation
-$81.75M$5.32-$0.15arrow_drop_down2.74%_$29.74M-$185.50MAI Analysis
Asset logo for symbol DM
DMDesktop Metal
-$81.93M$4.64-$0.05arrow_drop_down1.06%_$534.00K-$117.75MAI Analysis
Asset logo for symbol TPIC
TPICTPI Composites
-$82.62M$4.42-$0.16arrow_drop_down3.49%_$121.99M-$117.10MAI Analysis
Showing 4601-4620 of 4977
Results per page:

Cash flow is the lifeblood of any company, and at Stocklytics, we bring you a powerful tool to evaluate stocks based on their cash-generating abilities. The Cash Flow Screener ranks stocks in descending order of Operating Cash Flow, giving you instant access to companies with robust cash flow management. In addition to Operating Cash Flow, our screener includes insights into other key cash flow metrics: - Investing Cash Flow – Understand how a company allocates capital for growth, including expenditures on acquisitions, property, and equipment. - Financing Cash Flow – Analyze a company’s financial structure by examining cash flows from debt, equity issuance, dividends, and buybacks. - Free Cash Flow – Discover companies with strong free cash flow, an important indicator of financial health and flexibility. - With Stocklytics Cash Flow Screener, you can make data-driven decisions by focusing on companies with strong cash flow performance across multiple categories. Why Cash Flow Matters: - Operating Cash Flow – Provides insight into a company’s ability to generate cash from its core operations. - Investing Cash Flow – Helps gauge long-term investment strategies and capital allocation decisions. - Financing Cash Flow – Offers a window into a company’s financial maneuvers, such as debt repayment and shareholder returns. - Free Cash Flow – Indicates the cash available to a company after all expenses, crucial for evaluating long-term profitability and sustainability.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level